The European Union Medical Device Regulation (EU MDR) significantly reshaped the landscape for medical device manufacturers, introducing stringent regulatory requirements aimed at enhancing patient safety and device efficacy. Enforced since May 2021, the MDR replaced the older Medical Device Directive (MDD), demanding greater transparency and accountability from manufacturers operating within the EU market.
Navigating the complex landscape of global medical device regulations can be a daunting task for regulatory professionals and medical device companies. With each country enforcing its own set of rules and standards, ensuring compliance across multiple markets requires a strategic approach and in-depth knowledge. This guide aims to provide you with key insights and strategies to master multi-country medical device regulations, helping you expand your market reach effectively and confidently.
In today’s rapidly evolving regulatory landscape, medical device companies face increasingly complex challenges in bringing their products to market and maintaining compliance across multiple jurisdictions. The good news is that technological advancements, particularly in artificial intelligence (AI), machine learning (ML), and automation, are revolutionizing the field of regulatory affairs. These innovations are not just buzzwords; they’re powerful tools that can streamline workflows, reduce errors, and significantly accelerate time-to-market for medical devices.
We are excited to announce that RegDesk, the innovative Regulatory Information Management (RIM) platform, has been recognized as a Representative Vendor in the Gartner® Market Guide for Life Sciences Regulatory Information Management. Read the complimentary Market Guide for RIM Solutions report to learn more!
The article provides additional details regarding the approach to be applied with respect to certain types of medical devices in terms of regulatory flexibility. Table of Contents Introduction The Food and Drug Administration (FDA), a Philippines regulatory agency in...
The new article addresses the aspects related to the design considerations for diagnostic clinical performance studies. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has...